Healio (10/17, Herpen) reports, “Nonadherence to treatment with buprenorphine is associated with an increased risk of opioid overdose as well as increased spending for healthcare among Medicare participants,” researchers concluded in a study that included “a total of 34,505 U.S. Medicare fee-for-service beneficiaries…diagnosed with opioid use disorder who received at least one two-week period of continuous buprenorphine treatment between 2010 and 2017.” The findings were published online Oct. 5 in JAMA Psychiatry.
Related Links:
— “Buprenorphine treatment gaps linked to increased overdose risk, higher care spending “Robert Herpen, Healio, October 17, 2022